{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T06:26:45Z","timestamp":1775197605970,"version":"3.50.1"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Comprehensive Psychiatry"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1016\/j.comppsych.2016.12.006","type":"journal-article","created":{"date-parts":[[2016,12,27]],"date-time":"2016-12-27T19:46:45Z","timestamp":1482868005000},"page":"9-14","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["Clinical characterization of autoimmune encephalitis and psychosis"],"prefix":"10.1016","volume":"74","author":[{"given":"Qinjian","family":"Hao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dahai","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lanting","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.comppsych.2016.12.006_bb0005","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1093\/brain\/awh077","article-title":"Potassium channel antibody-associated encephalopathy: a potentially immunotherapy-responsive form of limbic encephalitis","volume":"127","author":"Vincent","year":"2004","journal-title":"Brain"},{"key":"10.1016\/j.comppsych.2016.12.006_bb0010","doi-asserted-by":"crossref","first-page":"5866","DOI":"10.1523\/JNEUROSCI.0167-10.2010","article-title":"Cellular and synaptic mechanisms of anti-NMDA receptor encephalitis","volume":"30","author":"Hughes","year":"2010","journal-title":"J Neurosci"},{"key":"10.1016\/j.comppsych.2016.12.006_bb0015","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/j.jocn.2013.07.017","article-title":"Autoimmune encephalitis: recent updates and emerging challenges","volume":"21","author":"Ramanathan","year":"2014","journal-title":"J Clin Neurosci"},{"key":"10.1016\/j.comppsych.2016.12.006_bb0020","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1212\/WNL.0b013e318224afde","article-title":"Encephalitis and antibodies to synaptic and neuronal cell surface proteins","volume":"77","author":"Lancaster","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.comppsych.2016.12.006_bb0025","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1002\/ana.21917","article-title":"Antibodies to glutamic acid decarboxylase define a form of limbic encephalitis","volume":"67","author":"Malter","year":"2010","journal-title":"Ann Neurol"},{"key":"10.1016\/j.comppsych.2016.12.006_bb0030","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.jneuroim.2009.04.010","article-title":"Autoantibodies to glutamic acid decarboxylase (GAD) in focal and generalized epilepsy: a study on 233 patients","volume":"211","author":"Errichiello","year":"2009","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.comppsych.2016.12.006_bb0035","doi-asserted-by":"crossref","first-page":"682.e1","DOI":"10.1016\/j.genhosppsych.2013.05.005","article-title":"Limbic encephalitis and psychosis","volume":"35","author":"Shah","year":"2013","journal-title":"Gen Hosp Psychiatry"},{"key":"10.1016\/j.comppsych.2016.12.006_bb0040","article-title":"Anti-NMDA receptor encephalitis in a patient with previous psychosis and neurological abnormalities: a diagnostic challenge","volume":"2015","author":"Heekin","year":"2015","journal-title":"Case Rep Psychiatry"},{"key":"10.1016\/j.comppsych.2016.12.006_bb0045","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.yebeh.2015.12.041","article-title":"Clinical characterization of autoimmune LGI1 antibody limbic encephalitis","volume":"56","author":"Gao","year":"2016","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.comppsych.2016.12.006_bb0050","doi-asserted-by":"crossref","first-page":"3023","DOI":"10.4103\/0366-6999.168989","article-title":"Limbic encephalitis associated with anti-\u03b3-aminobutyric acid B receptor antibodies: a case series from China","volume":"128","author":"Guan","year":"2015","journal-title":"Chin Med J"},{"key":"10.1016\/j.comppsych.2016.12.006_bb0055","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s13760-015-0517-x","article-title":"Assessing the clinical features of LGI1 antibody encephalitis","volume":"116","author":"Zhao","year":"2016","journal-title":"Acta Neurol Belg"},{"key":"10.1016\/j.comppsych.2016.12.006_bb0060","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1159\/000435953","article-title":"Anti-NMDAR encephalitis of 11 cases in China-detailed clinical, laboratory and Imagiological description","volume":"74","author":"Liu","year":"2015","journal-title":"Eur Neurol"},{"key":"10.1016\/j.comppsych.2016.12.006_bb0065","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1093\/brain\/awn092","article-title":"IgG1 antibodies to acetylcholine receptors in \u2018seronegative'myasthenia gravis","volume":"131","author":"Leite","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.comppsych.2016.12.006_bb0070","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1212\/01.wnl.0000325917.48466.55","article-title":"Neuronal surface antigen antibodies in limbic encephalitis clinical\u2013immunologic associations","volume":"71","author":"Graus","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.comppsych.2016.12.006_bb0075","doi-asserted-by":"crossref","first-page":"189","DOI":"10.2174\/157340011797183184","article-title":"Anti-NMDA receptor encephalitis in psychiatry","volume":"7","author":"Kayser","year":"2011","journal-title":"Curr Psychiatr Rev"},{"key":"10.1016\/j.comppsych.2016.12.006_bb0080","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1017\/S003329171300295X","article-title":"Prevalence of anti-N-methyl-D-aspartate (NMDA) receptor antibodies in patients with schizophrenia and related psychoses: a systematic review and meta-analysis","volume":"44","author":"Pollak","year":"2014","journal-title":"Psychol Med"},{"key":"10.1016\/j.comppsych.2016.12.006_bb0085","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1176\/appi.neuropsych.23.1.90","article-title":"The emerging link between autoimmune disorders and neuropsychiatric disease","volume":"23","author":"Kayser","year":"2011","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"10.1016\/j.comppsych.2016.12.006_bb0090","article-title":"Encephalopathy in children: an approach to assessment and management","author":"Davies","year":"2011","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.comppsych.2016.12.006_bb0095","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1017\/S0317167100013147","article-title":"Autoimmune encephalopathies and epilepsies in children and teenagers","volume":"39","author":"Wong-Kisiel","year":"2012","journal-title":"Can J Neurol Sci"},{"key":"10.1016\/j.comppsych.2016.12.006_bb0100","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1176\/appi.ajp.2011.11030516","article-title":"Autoimmune diseases and severe infections as risk factors for schizophrenia: a 30-year population-based register study","volume":"168","author":"Benros","year":"2011","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.comppsych.2016.12.006_bb0105","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1176\/appi.ajp.2013.13010086","article-title":"A nationwide study on the risk of autoimmune diseases in individuals with a personal or a family history of schizophrenia and related psychosis","volume":"171","author":"Benros","year":"2014","journal-title":"Am J Psychiatr"},{"key":"10.1016\/j.comppsych.2016.12.006_bb0110","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1111\/j.1399-5618.2010.00853.x","article-title":"Autoimmune diseases, bipolar disorder, and non-affective psychosis","volume":"12","author":"Eaton","year":"2010","journal-title":"Bipolar Disord"},{"key":"10.1016\/j.comppsych.2016.12.006_bb0115","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/S1474-4422(08)70224-2","article-title":"Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies","volume":"7","author":"Dalmau","year":"2008","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.comppsych.2016.12.006_bb0120","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1093\/brain\/awq113","article-title":"N-methyl-D-aspartate antibody encephalitis: temporal progression of clinical and paraclinical observations in a predominantly non-paraneoplastic disorder of both sexes","volume":"133","author":"Irani","year":"2010","journal-title":"Brain"},{"key":"10.1016\/j.comppsych.2016.12.006_bb0125","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S1474-4422(09)70324-2","article-title":"Antibodies to the GABA B receptor in limbic encephalitis with seizures: case series and characterisation of the antigen","volume":"9","author":"Lancaster","year":"2010","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.comppsych.2016.12.006_bb0130","series-title":"The prevalence of autoimmune encephalitis in patients presenting with first-episode psychosis","author":"Scott","year":"2016"},{"key":"10.1016\/j.comppsych.2016.12.006_bb0135","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.jns.2007.11.004","article-title":"CSF findings in patients with voltage gated potassium channel antibody associated limbic encephalitis","volume":"268","author":"Jarius","year":"2008","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.comppsych.2016.12.006_bb0140","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.seizure.2015.04.005","article-title":"CSF findings in patients with anti-N-methyl-D-aspartate receptor-encephalitis","volume":"29","author":"Wang","year":"2015","journal-title":"Seizure"},{"key":"10.1016\/j.comppsych.2016.12.006_bb0145","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S1474-4422(10)70253-2","article-title":"Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis","volume":"10","author":"Dalmau","year":"2011","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.comppsych.2016.12.006_bb0150","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1097\/PRA.0000000000000100","article-title":"A case of anti-NMDA receptor encephalitis treated with ECT","volume":"21","author":"Jones","year":"2015","journal-title":"J Psychiatr Pract"}],"container-title":["Comprehensive Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010440X16304539?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010440X16304539?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,5]],"date-time":"2018-09-05T14:23:02Z","timestamp":1536157382000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0010440X16304539"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":30,"alternative-id":["S0010440X16304539"],"URL":"https:\/\/doi.org\/10.1016\/j.comppsych.2016.12.006","relation":{},"ISSN":["0010-440X"],"issn-type":[{"value":"0010-440X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical characterization of autoimmune encephalitis and psychosis","name":"articletitle","label":"Article Title"},{"value":"Comprehensive Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.comppsych.2016.12.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}